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Abstract
Background: In Korea, the cumulative number of HIV-infected individuals was smaller than those of
other countries. Mandatory HIV tests, dominating method until 1990's, have been gradually changed to
voluntary HIV tests. We investigated HIV seroprevalence status and its characteristics of visitors to Public
Health Centers (PHCs), which conducted both mandatory test and voluntary test under the national HIV/
STI surveillance program.
Methods: We used HIV-testing data from 246 PHCs in 2005 through the Health Care Information
System. The number of test taker was calculated using the code distinguished by the residential
identification number. The subjects were classified into four groups by reason for testing; General group,
HIV infection suspected group (HIV ISG), HIV test recommended group (HIV TRG), and sexually
transmitted infection (STI) risk group.
Results: People living with HIV/AIDS were 149 (124 male and 25 female) among 280,456 individuals tested
at PHCs. HIV seroprevalence was 5.3 per 10,000 individuals. Overall, the male revealed significantly higher
seroprevalence than the female (adjusted Odds Ratio (adj. OR): 6.2; CI 3.8–10.2). Individuals aged 30–39
years (adj. OR: 2.6; CI 1.7–4.0), and 40–49 years (adj. OR: 3.8; CI 2.4–6.0) had higher seroprevalence than
20–29 years. Seroprevalence of HIV ISG (voluntary test takers and cases referred by doctors) was
significantly higher than those of others. Foreigners showed higher seroprevalence than native Koreans
(adj. OR: 3.8; CI 2.2–6.4). HIV ISG (adj. OR: 4.9; CI 3.2–7.5), and HIV TRG (adj. OR: 2.6; CI 1.3–5.4) had
higher seroprevalence than General group.
Conclusion: A question on the efficiency of current mandatory test is raised because the seroprevalence
of mandatory test takers was low. However, HIV ISG included voluntary test takers was high in our result.
Therefore, we suggest that Korea needs to develop a method encouraging more people to take voluntary
tests at PHCs, also to expand the anonymous testing centers and Voluntary Counselling and Testing
Program (VCT) for general population to easily access to HIV testing.
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Background
The first case of acquired immunodeficiency syndrome
(AIDS) in Korea was a foreign resident, and the first
human immunodeficiency virus (HIV)-infected Korean
contracted the virus during overseas travel in 1985 [1].
This stimulated a national preventative system for this
emerging infection in Korea, which became prevalent in
the United States and Europe in the early 1980s [2,3]. In
1985, mandatory HIV tests were established in commer-
cial sex workers (CSWs) with sexual contact with foreign-
ers [1,4], and in 1986 mandatory test was expanded to
CSWs with sexual contact with Koreans and hemophili-
acs. Prison inmates and donated blood samples were
included in the mandatory testing group in July 1987 [5].
HIV mandatory testing was extended to seafarers with
long-term overseas contracts in 1988 [6], and voluntary
anonymous HIV testing was allowed to ensure broader
screening in 1989. Article 8 of the Prevention Act for
Acquired Immunological Deficiency Syndrome (1986)
established the national surveillance system for the detec-
tion of HIV-positive individuals. Public health centers
(PHCs) were instructed to conduct HIV screening tests for
sexually transmitted infection (STI) risk groups periodi-
cally, and for volunteer groups arbitrarily [7]. The number
of mandatory HIV tests in Korea reached approximately 2
million until 1997, with the addition of hair salon
employees, restaurant employees, and food industry
employees, food industry sanitation workers and public
health personnel. However, in 1998 the Korean govern-
ment amended the HIV testing policy from mandatory
testing to voluntary testing by the Act of Health Check for
Food Industry Employees and Others. This exempted res-
taurant, food industry employees and others from manda-
tory HIV testing [8].
UNAIDS estimated 40.3 million people living worldwide
with HIV/AIDS in 2005, and AIDS-associated deaths were
up to 20 million [9]. HIV/AIDS has been expanding rap-
idly in India, China, and Southeast Asia. China has
increased recently with an estimated 650,000 infected
individuals [10]. The seroprevalence in Russia increased
more than five times from 1997 to 2002 [11]. Frequent
visits between Korea and these countries might have
increased the risk of individuals spreading HIV/AIDS in
Korea [12]. The percentage of HIV infections in Korean
adults aged 19–45 years as estimated by the World Health
Organization (WHO) in 2003 was relatively low at 0.01%
[13]. A total of 4,341 HIV infections were identified in
Korea from 1985 to 2005, including 88% Korean and
12% foreigners. The proportion of HIV infections in the
male (89%) was much higher than that in the female
(11%) [14]. The number of newly diagnosed HIV infec-
tions has increased yearly in Korea since 1998: 137 in
1998, 244 in 2000, 457 in 2002, and 763 in 2004 [14].
The Korean government conducted various projects to
slow down the increasing HIV infection; HIV diagnosis
and financial support of treatment were offered for people
living with HIV/AIDS (PLWHA) [14]. There are no epide-
miological studies to estimate or project the rate of HIV
transmission and to evaluate HIV/AIDS prevention
projects in Korea, even any investigation about essential
HIV seroprevalence. As the one of HIV testing centers in
Korea, PHCs are responsible to implement HIV/STI pre-
vention for the susceptible, low-income individual, and
the anonymous, through taking both HIV mandatory test-
ing and voluntary testing under national HIV surveillance
system. In 2005, PHCs conducted about 6% of HIV tests
in Korea, and detected approximately 19% of newly diag-
nosed HIV infections [15]. It was urgent to identify the sta-
tus of HIV seroprevalence among visitors to PHCs whose
HIV positivity was higher than other HIV test centers.
Therefore, we investigated HIV seroprevalence status and
its characteristics of visitors to PHCs.
Methods
Data Collection
PHCs in Korea have adopted a nationally incorporated
computerized data processing system, known as the
health care information system (HCIS), since 2000. The
system handles various health-related test results along
with other demographic and laboratory information. A
total of 372,692 HIV tests were carried out at 246 PHCs in
2005. The following data from the HCIS were collected
from each center: institutional identification, reception
number, reception date, gender, date of birth, residence
areas, test method, test kit, test result, reason for testing,
and code. The code is a parameter to identify the testing
frequency of each individual, and it is linked to each resi-
dential identification number (RID, 13 digit numbers),
unique number for each Korean, which is coded by the
date of birth, gender, birth place and check number. The
RID were declared during initial testing and in subsequent
tests the unique code was internally assigned inside HCIS.
The RID cannot be deduced from the code and it ensures
an individual's confidentiality.
Public HIV testing system under the National HIV 
surveillance
In Korea, HIV reactive samples from primary screening
tests at PHCs are referred to local Institute of Health &
Environment (IHE) for confirmatory testing. There are 17
local IHEs in 7 cities and in 10 provinces. Confirmed pos-
itive samples are referred to the division of AIDS at the
Korean Centers for Disease Control and Prevention
(KCDC), and the division makes final decision on HIV
infection status for each sample [7].
Subjects
All individuals in this study took free of charge HIV testing
for personal physical examinations in community healthBMC Public Health 2009, 9:123 http://www.biomedcentral.com/1471-2458/9/123
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improvement programs by PHCs. There were 14 reasons
for HIV testing by the HCIS, and these were classified into
four groups: The General group, the HIV infection sus-
pected group (HIV ISG), the HIV test recommended group
(HIV TRG), and the STI risk group. We grouped the STI
risk group and the HIV TRG according to the "Guidelines
for HIV/AIDS control" [7]. Individuals in the General
group took HIV test as a part of health checkup, and the
HIV ISG took HIV test based on suspicion of HIV infection
(Table 1). As anonymous tests could not determine the
number of individuals, it was not included in the sero-
prevalence estimates. We calculated the positivity for the
anonymous testing group.
Data Analysis
HIV seroprevalence was defined as the number of con-
firmed PLWHA divided by total number of HIV-tested
individuals during the study period. Initially indetermi-
nate samples that were positive on follow-up were
included as HIV positive samples, and the first test date
was defined as the date of diagnosis.
Tests without full RID or with incorrect RID (19,252
tests), and anonymous cases (9,877 tests) were excluded
from the initial 372,692 tests. The testing frequency of
each individual in a single year was referred to as the
repeated number. The mean of the repeated number was
calculated in each group and by gender. HIV seropreva-
lence was expressed as the number of PLWHA per 10,000
individuals. Logistic regression analysis was performed to
examine factors that were independently associated with
HIV seroprevalence. The multi-variable models were fit
adjusting for variables (gender, age group, nationality,
region, and reason for testing). Statistical significance (p <
0.05) was defined at the 95% confidence interval. All sta-
tistical analyses were performed using SAS 9.1.
Results
A total of 280,456 individuals were tested at 246 PHCs in
2005, and 149 PLWHA were identified. The repeated
number was significantly greater in the STI risk groups
than in other groups (p < 0.0001), and there were statisti-
cally significant differences in the repeated number
between the male and the female in the HIV ISG and the
STI risk groups, but not for the General group and the HIV
TRG (Figure 1).
Table 2 presents demographic data about HIV seropreva-
lence in Korea. The female accounted for 68.7% of all
tested individuals (n = 280,456), and twenties were the
leading group (45.4%) while metropolitan city dweller
took 40.4%. The STI risk group was outstanding (51.6%)
in reason for testing. Overall HIV seroprevalence was 5.3
per 10,000 individuals and the male showed significantly
higher seroprevalence than the female (adjusted Odds
Ratio (adj, OR), 6.2; 95% Confidence Interval (CI), 3.8–
Table 1: Classification of the reason for HIV testing of visitors to public health centers in Korea (2005).
Class Reason for HIV testing Regulation
General group - Health checkup: a comprehensive physical 
examination
- Medical certificate: to apply for workplace 
permits, residence halls, licenses, officers, 
workers, welfare centers, detention centers 
and in shelters for women.
- Prenatal checkup
- Others: Employees of motels, restaurants, 
and beauty salons, etc.
Voluntary testing
(but medical certificate for a job or residence 
appeared to be by routine testing.).
HIV infection s
uspected group
(HIV ISG)
- Referral by doctor: to take additional HIV 
tests when doctors suspect HIV infection at 
diagnosis
- Voluntary test taker: to take HIV test as 
identified if suspicious.
Voluntary testing (because doctors or 
themselves are suspicious about HIV infection).
HIV test recommended group (HIV TRG) - Tuberculosis patient
- Prisoner
- Partner of HIV-infected individual
Though routine test regulated by "Guideline 
for HIV/AIDS control.
Sexually transmitted infection risk group 
(STI risk group)
- Commercial sex worker(CSW)
- Bar employee
- Tea-room employee
- Massage parlor
- Others: one of the above four categories, 
but not specified
Mandatory testing except male, regular 
mandatory HIV tests are taken every six 
months by "Guideline for HIV/AIDS control" to 
prevent the spread of HIV to general 
population.BMC Public Health 2009, 9:123 http://www.biomedcentral.com/1471-2458/9/123
Page 4 of 9
(page number not for citation purposes)
10.2). HIV seroprevalence in the aged 30–39 years (adj.
OR, 2.6; 95% CI, 1.7–4.0), and the aged 40–49 years (adj.
OR, 3.8; 95% CI, 2.4–6.0) was higher than that in the
aged 20–29 years as a reference. HIV seroprevalence in
9,959 foreigners was 18.1 cases per 10,000 individuals,
and this was significantly higher than the seroprevalence
among native Koreans (adj. OR, 3.8, 95% CI, 2.2–6.4).
Small towns or rural areas revealed lower HIV seropreva-
lence than the metropolitan cities (adj. OR, 0.5; 95% CI,
0.4–0.7). The HIV ISG (adj. OR, 4.9; 95% CI, 3.2–7.5)
and the HIV TRG (adj. OR, 2.6; 95% CI, 1.3–5.4) had
higher seroprevalence than the General group. The lowest
seroprevalence was seen in the STI risk group (1.5 per
10,000 individuals), but this was not significantly differ-
ent from the General group (adj. OR, 1.1; 95% CI, 0.6–
2.0) after adjusted by gender, age, nationality, and region.
Table 3 presents the characteristics of HIV seroprevalence
by reason for testing. Only in the HIV TRG, the male did
not show significant difference from the female. Foreign-
ers showed significantly higher seroprevalence in the Gen-
eral group (21.0 per 10,000 individuals) than in the STI
risk group (14.1 per 10,000 individuals). There were no
HIV positive foreigners identified in the HIV ISG and in
the HIV TRG. Both groups displayed significantly higher
seroprevalence than other groups in metropolitan cities (p
< 0.05). For the HIV ISG, the seroprevalence was very high
in the male (30.2 per 10,000 individuals), also the aged
30–39 years (37.9 per 10,000 individuals) and the aged
40–49 years (38.8 per 10,000 individuals) were very high.
Among fourteen subgroups, the major parts taking tests
were occupied by bar employees (31.2%) followed by the
visitors requiring medical certificates (14.7%). Partners of
HIV-infected individuals had the highest seroprevalence,
followed sequentially by voluntary test takers (23.8 per
10,000 individuals), individuals referred by doctors (19.6
per 10,000 individuals), and prisoners (15.4 per 10,000
individuals). While there were no noticeable differences
in the General group or the STI risk group after adjusted
by gender, age, nationality, and region, individuals
referred by doctors (adj. OR, 3.6; 95% CI, 1.7–7.5) and
voluntary test takers (adj. OR, 5.7; 95% CI 2.8–11.8) had
higher HIV seroprevalence than individuals for health
checkup as a reference (Table 4).
Discussion
HIV testing policy in Korea has been changed. Mandatory
HIV testing was dominated until 1990's and it gradually
has been moved to the voluntary HIV testing in hospitals
The number of HIV test by gender and HIV test reason groups Figure 1
The number of HIV test by gender and the group of reason for HIV testing (2005). HIV TRG: HIV test recommend 
group. HIV ISG: HIV infection suspected group.  STI: sexually transmitted infection. Gender; male p<.0001, female p<.0001 
Reason for HIV testing; General group P=0.1905, HIV TRG P=0.8971, HIV ISG P=0.0046, STI risk group P<0.0001
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or clinics. In 2005, hospitals or clinics conducted 55% of
HIV screening tests in Korea, and detected 75% of the
newly diagnosed HIV infections. [16] However, the HIV
testing takers in PHCs occupied approximately 6% of the
screening tests and comprised 19% (149 individuals or
5.3 per 10,000 individuals) of the newly diagnosed in
Korea.
People aged 30–49 years, foreigners, metropolitan inhab-
itants, the HIV ISG, and the HIV TRG showed high sero-
prevalence. The high seroprevalence in the HIV ISG was
due to suspicions by doctors and voluntary test takers
experiencing symptoms or risky behaviors. The propor-
tion of HIV-infected male who found in 2005 was 94%
and all of them were infected by sexual contact. According
to survey for HIV transmission route, the proportion of
homosexual contact is 47.0%, heterosexual contact
52.8%, and others 0.2%. However, many males who were
categorized into heterosexual contacts at the initial inter-
view were later changed into homosexual contacts [17],
and it is doubtful if homosexual contact might be a dom-
inant route in Korea. Epidemiological studies for Japan
and Thailand showed high prevalent in the aged 30–49
years for men having sex with men (MSM) [18,19]. The
prevalent of the HIV ISG for the male and the aged 30–49
years might be due to MSM. However, we do not have any
information about this, and it will be requested to study
the sexual behavior in order to find the characteristics of
HIV transmission route in Korea.
HIV seroprevalence in the aged 20–29 years was lower
than those in older individuals. This is similar to the sero-
prevalence of herpes simplex virus type 2 (HSV-2) [20]
but differs from HIV seroprevalence in the U.S., Russia,
and the many European countries [21-23].
There are about 910,000 foreigners in Korea, and about
65% are from China, the Philippines, Thailand, Viet Nam,
and Russia. [24]. Foreigners who are engaged in entertain-
ment or sports for more than 3 months are required to
take HIV tests in accordance with the Prevention Act for
Acquired Immunological Deficiency Syndrome [7]. In
this study, foreigners revealed significantly higher sero-
prevalence than native Korean (p < 0.0001). Two of 18
HIV-infected foreigners belonged to the STI risk group
(14.1 per 10,000 individuals) and the others were
included the General group (21.0 per 10,000 individuals).
The major reason to take tests in the General group was to
get medical certification, which contributed to the high
seroprevalence. For the foreigners, medical certification
approved by a compulsory medical checkup is required
for a job or for residence, which may be a stricter require-
Table 2: HIV seroprevalence of visitors to public health centers in Korea (2005).
No. of HIV tested No. of HIV tested
individuals (%)
No. positive
(%)
HIV Seroprevalence
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Total 343563 280456 149 5.3 (4.5,6.5)
Gender
Female 251483 192687 (68.7) 25 (16.8) 1.3 (0.8,1.8) 1.0 1.0
Male 92080 87769 (31.3) 124 (83.2) 14.1 (11.6,16.6) 10.9 (7.1,16.8) 6.2 (3.8,10.2)
Age group
<20 17922 15587 (5.6) 4 (2.7) 2.6 (0.1,5.1) 0.9 (0.3,2.6) 0.6 (0.2,1.6)
20–29 165803 127393 (45.4) 35 (23.5) 2.7 (1.8,3.7) 1.0 1.0
30–39 86052 70723 (25.2) 56 (37.5) 7.9 (5.8,10.0) 2.9 (1.9,4.4) 2.6 (1.7,4.0)
40–49 43220 37559 (13.5) 41 (27.5) 10.9 (7.6,14.3) 4.0 (2.5,6.2) 3.8 (2.4,6.0)
50–59 16039 15196 (5.4) 8 (5.4) 5.3 (1.6,8.9) 1.9 (0.9,4.1) 1.4 (0.6,3.0)
60≤ 14527 13998 (4.9) 5 (3.4) 3.6 (0.4,6.7) 1.3 (0.5,3.3) 0.9 (0.4,2.3)
Nationality
Korean 333367 270497 (96.5) 131 (87.9) 4.8 (4.0,5.7) 1.0 1.0
Foreigner 10196 9959 (3.5) 18 (12.1) 18.1 (9.7,26.4) 3.7 (2.3,6.1) 3.8 (2.2,6.4)
Region
Metropolitan 134613 113290 (40.4) 87 (58.4) 7.7 (6.1,9.3) 1.0 1.0
Small town or rural 208950 167166 (59.6) 62 (41.6) 3.7 (2.8,4.6) 0.5 (0.3,0.7) 0.5 (0.4,0.7)
Reason for testing
General group 90628 88116 (31.4) 32 (21.5) 3.6 (2.4,4.9) 1.0 1.0
HIV ISG 43517 39502 (14.1) 86 (57.7) 21.8 (17.2,26.4) 6.0 (4.0,9.0) 4.9 (3.2,7.5)
HIV TRG 8351 8144 (2.9) 10 (6.7) 12.3 (4.7,19.9) 3.4 (1.7,6.9) 2.6 (1.3,5.4)
STI risk group 201067 144694 (51.6) 21 (14.1) 1.5 (0.8,2.1) 0.4 (0.2,0.7) 1.1 (0.6,2.0)
HIV seroprevalence: the number of people living with HIV/AIDS per 10,000 individuals. All data are excluded 9,877 anonymous cases and 19,252 
cases without full residential identification number (RID) or with incorrect RID. CI: Confidence Interval, OR: Odds Ratio. No. positive: the number 
of people living with HIV/AIDS.
HIV TRG: HIV test recommended group. HIV ISG: HIV infection suspected group. STI: sexually transmitted infection.B
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Table 3: Comparison in HIV seroprevalences of visitors to public health centers by reason for HIV testing in Korea (2005).
General group HIV ISG HIV TRG STI risk group
Individuals (%) HIV+ SP(95%CI) Individuals (%) HIV+ SP(95%CI) Individuals (%) HIV+ SP(95%CI) Individuals
(%)
HIV+ SP(95%CI)
Total 88116 32 3.6
(2.4–4.9)
39502 86 21.8
(17.2–26.4)
8144 10 12.3
(4.7–19.9)
144694 21 1.5
(0.8–2.1)
Gender
Female 48628 (55.2) 8 1.6
(0.5–2.8)
13055 (33.0) 6 4.6
(0.9–8.3)
2359 (29.1) 3 12.7
(0.0–27.1)
128645 (88.9) 8 0.6
(0.2–1.1)
Male 39488 (44.8) 24 6.1
(3.6–8.5)
26447 (67.0) 80 30.2
(23.6–36.9)
5785 (70.9) 7 12.1
(3.1–21.1)
16049 (11.1) 13 8.1
(3.7–12.5)
Age group
<20 6518 (7.4) 0 0.0 3230 (8.2) 3 9.3
(0.0–19.8)
951 (11.7) 0 0.0 4888 (3.4) 1 2.0
(0.0–6.1)
20–29 34290 (38.9) 12 3.5
(1.5–5.5)
14 673 (37.1) 15 10.2
(5.1–15.4)
1990 (24.4) 1 5.0
(0.0–14.9)
76440 (52.8) 7 0.9
(0.2–1.6)
30–39 22165 (25.2) 10 4.5
((1.7–7.3)
10302 (26.1) 39 37.9
(26.0–49.7)
1492 (18.3) 1 6.7
(0.0–19.8)
36764 (25.4) 6 1.6
(0.3–2.9)
40–49 9275 (10.5) 9 9.7
(3.4–16.0)
5663 (14.3) 22 38.8
(22.6–55.1)
1380 (17.0) 6 43.5
(8.8–78.2)
21241 (14.7) 4 1.9
(0.0–3.7)
50–59 7352 (8.3) 0 0.0 2872 (7.3) 4 13.9
(0.3–27.6)
832 (10.2) 1 12.0
(0.0–35.6)
4140 (2.9) 3 7.2
(0.0–15.4)
60 ≤ 8516 (9.7) 1 1.2
(0.0–3.5)
2762 (7.0) 3 10.9
(0.0–23.1)
1499 (18.4) 1 6.7
(0.0–19.7)
1221 (0.8) 0 0.0
Nationality
Korean 80508 (91.4) 16 2.0
(1.0–3.0)
38710 (98.0) 86 22.2
(17.5–26.9)
8002 (98.3) 10 12.5
(4.8–20.2)
143277 (99.0) 19 1.3
(0.7–1.9)
Foreigner 7608 (8.6) 16 21.0
(10.7–31.3)
792 (2.0) 0 0.0 142 (1.7) 0 0.0 1417 (1.0) 2 14.1
(0.0–33.7)
Region
Metropolitan 42563 (48.3) 18 4.2
(2.3–6.2)
17691 (44.8) 53 30.0
(21.9–38.0)
3956 (48.6) 7 17.7
(4.6–30.8)
49080 (33.9) 9 1.8
(0.6–3.6)
Small town or 
rural
45553 (51.7) 14 3.1
(1.5–4.7)
21811 (55.2) 33 15.1
(10.0–20.3)
4188 (51.4) 3 7.2
(0.0–15.3)
95614 (66.1) 12 1.3
(0.5–2.0)
HIV TRG: HIV test recommend group. HIV ISG: HIV infection suspected group. STI: sexually transmitted infection
Individuals: the number of HIV tested individuals, HIV+: the number of people living with HIV/ADIS, SP (HIV seroprevalence): the number of people living with HIV/AIDS per 10,000 individuals.
CI: Confidence IntervalBMC Public Health 2009, 9:123 http://www.biomedcentral.com/1471-2458/9/123
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ment compared with the cases of Koreans. About 12% of
the newly diagnosed HIV infections in PHCs were foreign-
ers. In Japan, this is 13% in 2004, which the infectious sta-
tus is similar to our result [25]. The Korean government
provides foreigners with free of charge HIV testing, coun-
seling, education, and medical tests in PHCs to prevent
domestic population from new HIV infection, also to take
care the foreigners' health.
The female in the STI risk group is to take a mandatory test
every six months, but we found that the number of HIV
test in them was less than twice per year. HIV-infected
females from the STI risk group cannot be gainfully
employed in businesses with routine testing. Therefore
people employed in the high risk industries will likely
take anonymous tests. If they are positive, they do not take
due mandatory test, will leave the industry or go under-
ground. The seroprevalence of female is lower in the STI
risk group than in the General group, so that the change
in testing policy for STI risk group need to be considered.
A limitation of mandatory testing was demonstrated in
Austria where HIV prevalence among registered CSWs is
0%, but it is 3.7% among illegal sex workers [26].
HIV infection is a major health problem in prisons
around the world [27,28], and they show higher seroprev-
alence than other groups in Korea, although the reasons
were not addressed in this study. HIV seroprevalence in
metropolitan cities was higher than that in small towns or
rural areas, and this result is similar to other countries
[29].
The HIV seroprevalence in tuberculosis (TB) patients
treated in PHCs was similar to that in the General group.
Although Korea is under low HIV prevalence, and is under
intermediate TB burden; the TB prevalence was estimated
12.3 per 10,000 in 2006 by WHO [30]. TB is the most
common opportunistic infection in AIDS patients, and
AIDS is a major cause of TB or pneumocystis-associated
deaths in Korea [31,32]. However, HIV testing is not com-
pulsory to TB patients in Korea, so it is difficult to find HIV
prevalence among them. Fortunately, we could find HIV
infections of TB patients in our study because TB patients
in PHCs were recommended to take HIV tests.
By statute, the STI risk group and the HIV TRG are
required to take mandatory testing at PHCs for the preven-
tion of HIV transmission, and the HIV ISG to take volun-
tary tests for early detection. For the General group, HIV
testing is free of charge, which leads low-income individ-
uals to take test in PHCs. We can find the status of sero-
prevalence in each group and compare to characteristics of
seroprevalence among groups, through taking mandatory
testing and voluntary testing under the national HIV sur-
Table 4: HIV seroprevalence of visitors to public health centers by reason for HIV testing in Korea (2005).
Group Subgroup No. of HIV tested
individuals
(%)
No. of positive HIV Seroprevalence
(95% CI)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Total 280456 149 5.3 (4.5–6.5) - -
General group Health Checkup 21598 (7.7) 9 4.2 (1.4–6.9) 1.0 1.0
Medical Certificate 41358 (14.7) 19 4.6 (2.5–6.7) 1.1 (0.5–2.4) 1.0 (0.4–2.3)
Prenatal Checkup 17159 (6.1) 2 1.2 (0.0–2.8) 0.3 (0.1–1.3) 1.2 (0.2–5.9)
Others* 8001 (2.9) 2 2.5 (0.0–6.0) 0.6 (0.1–1.0) 0.8 (0.1–1.4)
HIV ISG Referral by doctor 19359 (6.9) 38 19.6 (13.4–25.9) 4.7 (2.3–9.8) 3.6 (1.7–7.5)
Voluntary test taker 20143 (7.2) 48 23.8 (17.1–30.6) 5.7 (2.8–11.7) 5.7 (2.8–11.8)
HIV TRG TB patient 6822 (2.4) 3 4.4 (0.0–9.4) 1.1 (0.3–3.9) 0.9 (0.2–3.4)
Prisoner 1295 (0.5) 2 15.4 (0.0–36.8) 3.7 (0.8–17.2) 2.5 (0.5–11.6)
Partner of HIV-infected 
individual
27 (0.0) 5 1,852(387–3,317) 545 (169–999) 420 (110–999)
STI risk group CSW 399 (0.1) 0 0.0 - -
Bar employee 87602 (31.2) 12 1.4 (0.6–2.2) 0.3 (0.1–0.8) 0.9 (0.4–2.2)
Tea room employee 27353 (9.8) 2 0.7 (0.0–1.7) 0.2 (0.0–0.8) 0.8 (0.2–3.8)
Massage parlor 1535 (0.6) 0 0.0 - -
Others** 27805 (9.9) 7 2.5 (0.7–4.4) 0.6 (0.2–1.6) 2.1(0.7–5.9)
CI: Confidence Interval, OR: Odds Ratio, TB: tuberculosis, CSW; commercial sexual worker.
HIV TRG: HIV test recommended group. HIV ISG: HIV infection suspected group. STI: sexually transmitted infection.
*Employees of motels, restaurants, and beauty salons, etc.
**One among four subgroup in STI risk group, but not specified.BMC Public Health 2009, 9:123 http://www.biomedcentral.com/1471-2458/9/123
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veillance system. Our results were derived from the
national HIV surveillance data collected by the HCIS. HIV
seroprevalence of visitors to PHCs can be used for the
evaluation of community health policy as well as national
HIV/AIDS and STI policy. Therefore our results were
highly significant to the study of HIV epidemiology in
PHC testing takers.
Our study had several limitations. First, The General
group included about 31% of the total testing takers in
PHCs, and included major individuals with low income
who were tested due to job, or welfare requirement. There-
fore, patterns of HIV seroprevalence in the General group
identified in this study may not be nationally representa-
tive. Secondly, the seroprevalence in the STI risk group
may be underestimated because of the possibility that the
individuals could undergo anonymous testing prior to
mandatory testing. Third, the HIV seroprevalence (5.3 per
10,000 individuals) might be underestimated due to
excluding the anonymous testing takers. In 2005, 35 HIV
positive cases were detected among 9,877 anonymous
tests at PHCs and their positivity were very higher for 35.4
per 10,000 tests. Fourth, getting medical certification for a
job or residence application in the General group seems to
be mandatory currently. This is more common in foreign
workers.
Conclusion
UNAIDS/WHO do not support mandatory testing of indi-
viduals except blood donors on public health grounds.
Voluntary testing is more likely to result in behaviors
change to avoid transmission HIV [33]. Also, our result
revealed that voluntary testing might be superior in iden-
tification of HIV-infected individuals, since HIV seroprev-
alence was low in the STI risk group while high in the HIV
ISG. In addition, the mandatory testing on STI risk group
raises a conflicting issue between human rights of the
group vs. prevention of STI transmission. It is currently
discussed to change the policy on the national HIV testing
in Korea. We suggest there are needs in Korea to develop
a method encouraging more people to take voluntary tests
at PHCs and also to expand anonymous testing centers
and Voluntary Counseling and Testing Program (VCT) for
general population to easily access to HIV testing.
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